Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Coronavirus Stock CureVac Crushed It on Thursday

TheMotleyFool

0 0

Why Coronavirus Stock CureVac Crushed It on Thursday

Shares of CureVac (NASDAQ: CVAC) surged almost 17% higher on Thursday after the company announced it found a well-capitalized and famous partner to help get its coronavirus vaccine to market.

CureVac said it has signed a collaboration and services agreement with global pharmaceutical powerhouse Bayer (OTC: BAYR.Y) regarding the former's coronavirus vaccine candidate, CVnCoV.

Image source: Getty Images.

Source Fool.com

Like: 0

CVAC

Share